Skip to main content

Advertisement

Log in

Serum cystatin C is associated with carotid atherosclerosis in patients with acute ischemic stroke

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Accumulating studies have shown that cystatin C may play important roles in the pathogenesis of arteriosclerosis. However, the association between serum cystatin C and the characteristics of carotid plaques has not been elucidated. Furthermore, the diagnostic value of serum cystatin C in carotid stenosis has not been studied.

Methods

Serum cystatin C in 156 patients with acute ischemic stroke (AIS) in the carotid artery was measured by ELISA. Intima-media thickness (IMT), stenosis of the symptomatic common carotid artery (CCA), extra/intracranial internal carotid artery (ICA) stenosis, and plaque characteristics were measured and recorded. Receiver operating characteristic (ROC) curves were used to assess the diagnostic value of serum cystatin C in carotid stenosis.

Results

One hundred fifty-six patients were divided into two groups based on their cystatin C levels. The degree of arteriosclerosis, the severity of plaques, and stenosis of the symptomatic CCA were significantly higher in the patients with high cystatin C levels. In addition, the rate of unstable plaques was significantly higher in those with high cystatin C. Serum cystatin C levels of 1.075 and 1.125 mg/L had diagnostic value in distinguishing stenosis of CCA and extracranial ICA, respectively.

Conclusions

Higher cystatin C levels were strongly correlated with symptomatic CCA stenosis and the rate of unstable plaques. Analysis of cystatin C levels may be useful for the identification of CCA stenosis and extracranial ICA in patients with AIS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Liu M, Wu B, Wang W-Z, Lee L-M, Zhang S-H, Kong L-Z (2007) Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 6(5):456–464. https://doi.org/10.1016/s1474-4422(07)70004-2

    Article  PubMed  Google Scholar 

  2. Jander S, Sitzer M, Wendt A, Schroeter M, Buchkremer M, Siebler M, Muller W, Sandmann W, Stoll G (2001) Expression of tissue factor in high-grade carotid artery stenosis - association with plaque destabilization. Stroke 32(4):850–854. https://doi.org/10.1161/01.str.32.4.850

    Article  CAS  PubMed  Google Scholar 

  3. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ (2001) Primary prevention of ischemic stroke - a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103(1):163–182

    Article  CAS  Google Scholar 

  4. Hillen T, Nieczaj R, Munzberg H, Schaub R, Borchelt M, Steinhagen-Thiessen E (2000) Carotid atherosclerosis, vascular risk profile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin Ageing Study. J Intern Med 247(6):679–688. https://doi.org/10.1046/j.1365-2796.2000.00681.x

    Article  CAS  PubMed  Google Scholar 

  5. He X-W, Ke S-F, Bao Y-Y, Hong W-J, Shen Y-G, Li C, Zhu F, Wang E, Jin X-P (2018) Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke. Clin Chim Acta 478:157–161. https://doi.org/10.1016/j.cca.2017.1.2.940

    Article  CAS  PubMed  Google Scholar 

  6. Wu W, Guan Y, Xu K, Fu X-J, Lei X-F, Lei L-J, Zhang Z-Q, Cheng Y, Li Y-Q (2016) Plasma Homocysteine levels predict the risk of acute cerebral infarction in patients with carotid artery lesions. Mol Neurobiol 53(4):2510–2517. https://doi.org/10.1007/s12035-015-9226-y

    Article  CAS  PubMed  Google Scholar 

  7. Xu Z, Leng C, Yang B, Wang H, Sun J, Liu Z, Yang L, Ge W, Zhu J (2017) Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke. Oncotarget 8(40):67181–67188. https://doi.org/10.18632/oncotarget.18061

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhang Y, Sun L (2017) Cystatin C in cerebrovascular disorders. Curr Neurovasc Res 14(4):406–414. https://doi.org/10.2174/1567202614666171116102504

    Article  CAS  PubMed  Google Scholar 

  9. Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65(4):1416–1421. https://doi.org/10.1111/j.1523-1755.2004.00517.x

    Article  CAS  PubMed  Google Scholar 

  10. Doganer YC, Aydogan U, Aparci M, Nerkiz P, Barcin C, Cayci T, Sari O (2014) Comparison of cystatin-C and pentraxin-3 in coronary atherosclerosis. Coron Artery Dis 25(7):589–594. https://doi.org/10.1097/mca.0000000000000132

    Article  PubMed  Google Scholar 

  11. Longenecker CT, Hileman CO, Funderburg NT, McComsey GA (2014) Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV Trial. Clin Infect Dis 59(8):1148–1156. https://doi.org/10.1093/cid/ciu523

    Article  PubMed  PubMed Central  Google Scholar 

  12. (1989) Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 20(10):1407–1431

  13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41

    Article  Google Scholar 

  14. Schumacher HC, Meyers PM, Higashida RT, Derdeyn CP, Lavine SD, Nesbit GM, Sacks D, Rasmussen P, Wechsler LR (2010) Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis (reprinted from Stroke 2009, VOL 40, PG 348-365). J Neurointerv Surg 2(4):324–340. https://doi.org/10.1136/jnis.2010.002345

    Article  PubMed  Google Scholar 

  15. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KEJ, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT (2003) From vulnerable plaque to vulnerable patient - a call for new definitions and risk assessment strategies: part I. Circulation 108(14):1664–1672. https://doi.org/10.1161/01.cir.0000087480.94275.97

    Article  PubMed  Google Scholar 

  16. Sztajzel R (2005) Ultrasonographic assessment of the morphological characteristics of the carotid plaque. Swiss Med Wkly 135(43–44):635–643

    PubMed  Google Scholar 

  17. MRC European Carotid Surgery Trial (1991) Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet (London, England) 337(8752):1235–1243. https://doi.org/10.1016/0140-6736(91)92916-p

    Article  Google Scholar 

  18. Ebesunun MO, Obajobi EO (2012) Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. Pan Afr Med J 12:48

    PubMed  PubMed Central  Google Scholar 

  19. Seliger SL, Longstreth WT, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS (2005) Cystatin C and subclinical brain infarction. J Am Soc Nephrol 16(12):3721–3727. https://doi.org/10.1681/asn.2005010006

    Article  CAS  PubMed  Google Scholar 

  20. Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, Fang K, Chapman HA, Shi GP (2005) Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 96(3):368–375. https://doi.org/10.1161/01.res.0000155964.34150.f7

    Article  CAS  PubMed  Google Scholar 

  21. Panayiotou AG, Griffin MB, Tyllis T, Georgiou N, Bond D, Humphries SE, Nicolaides AN (2013) Association of genotypes at the matrix metalloproteinase (MMP) loci with carotid IMT and presence of carotid and femoral atherosclerotic plaques. Vasc Med 18(5):298–306. https://doi.org/10.1177/1358863x13502698

    Article  PubMed  Google Scholar 

  22. Correa S, Morrow DA, Braunwald E, Davies RY, Goodrich EL, Murphy SA, Cannon CP, O'Donoghue ML (2018) Cystatin C for risk stratification in patients after an acute coronary syndrome. J Am Heart Assoc 7(20):e009077. https://doi.org/10.1161/jaha.118.009077

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI, Grp WS (2007) Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 69(22):2063–2068. https://doi.org/10.1212/01.wnl.0000279338.18776.26

    Article  CAS  PubMed  Google Scholar 

  24. Ferguson TW, Komenda P, Tangri N (2015) Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens 24(3):295–300. https://doi.org/10.1097/mnh.0000000000000115

    Article  CAS  PubMed  Google Scholar 

  25. Pottel H, Delanaye P, Schaeffner E, Dubourg L, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Ebert N (2017) Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant 32(3):497–507. https://doi.org/10.1093/ndt/gfw425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Betge S, Kretzschmar D, Figulla HR, Lichtenauer M, Jung C (2017) Predictive value of the augmentation index derived vascular age in patients with newly diagnosed atherosclerosis. Heart Vessel 32(3):252–259. https://doi.org/10.1007/s00380-016-0868-0

    Article  Google Scholar 

  27. Umemura T, Kawamura T, Mashita S, Kameyama T, Sobue G (2016) Higher levels of cystatin C are associated with extracranial carotid artery steno-occlusive disease in patients with noncardioembolic ischemic stroke. Cerebrovasc Dis Extra 6(1):1–11. https://doi.org/10.1159/000443338

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kataoka H (2009) Cathepsin enzymes and cystatin C: do they play a role in positive arterial remodeling? Response. Stroke 40(2):E28. https://doi.org/10.1161/strokeaha.108.538553

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianfei Nao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study conformed to Ethical Guidelines for Medical and Health Research Involving Human Subjects endorsed by the Chinese government.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, J., Dong, X. & Nao, J. Serum cystatin C is associated with carotid atherosclerosis in patients with acute ischemic stroke. Neurol Sci 41, 2793–2800 (2020). https://doi.org/10.1007/s10072-020-04383-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04383-9

Keywords

Navigation